title: Carpal tunnel syndrome in pregnancy.
abstract: During pregnancy, hormonal fluctuations, fluid shifts, and musculoskeletal changes predispose women to carpal tunnel syndrome. While the clinical presentation is similar to other patients, the history obtained must include information regarding the pregnancy itself. Currently, the indication for electrodiagnostic testing is not clearly defined. Given that symptoms often improve with conservative treatment and abate after delivery, EMG/NCV testing can often be avoided. However, if symptoms are severe or persist, carpal tunnel release is indicated and is considered a safe procedure for both mother and fetus.
authors.affiliation: Department of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA 19107, USA.
authors.forename: Meredith
authors.initials: M
authors.lastname: Osterman
authors.forename: Asif M
authors.initials: AM
authors.lastname: Ilyas
authors.forename: Jonas L
authors.initials: JL
authors.lastname: Matzon
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D002349:Carpal Tunnel Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D019299:Decompression, Surgical / Q000379:methods*; D004568:Electrodiagnosis / Q000379:methods; D005260:Female; D006801:Humans; D007270:Injections, Intra-Articular; D008475:Median Nerve / Q000503:physiopathology / Q000601:surgery; D018579:Patient Selection; D010808:Physical Examination / Q000379:methods; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D015995:Prevalence; D011379:Prognosis; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones